Nonetheless, certain targets, such as ICAM1, ANGPT1, and MAPK3, may hold therapeutic potential due to their roles in cardiovascular and inflammatory pathways, which are implicated in AF pathophysiology. The gene discussed is MAPK3; the disease is atrial fibrillation.